Logo image of IBM

INTL BUSINESS MACHINES CORP (IBM) Stock Fundamental Analysis

NYSE:IBM - US4592001014 - Common Stock

242.09 USD
+2.69 (+1.12%)
Last: 8/22/2025, 8:14:57 PM
242.38 USD
+0.29 (+0.12%)
After Hours: 8/22/2025, 8:14:57 PM
Fundamental Rating

4

Taking everything into account, IBM scores 4 out of 10 in our fundamental rating. IBM was compared to 83 industry peers in the IT Services industry. While IBM has a great profitability rating, there are quite some concerns on its financial health. IBM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IBM was profitable.
In the past year IBM had a positive cash flow from operations.
In the past 5 years IBM has always been profitable.
In the past 5 years IBM always reported a positive cash flow from operatings.
IBM Yearly Net Income VS EBIT VS OCF VS FCFIBM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

IBM's Return On Assets of 3.93% is fine compared to the rest of the industry. IBM outperforms 65.06% of its industry peers.
IBM's Return On Equity of 21.20% is amongst the best of the industry. IBM outperforms 86.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.55%, IBM is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
IBM had an Average Return On Invested Capital over the past 3 years of 7.26%. This is significantly below the industry average of 22.12%.
The last Return On Invested Capital (7.55%) for IBM is above the 3 year average (7.26%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.93%
ROE 21.2%
ROIC 7.55%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
IBM Yearly ROA, ROE, ROICIBM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

IBM has a better Profit Margin (9.11%) than 77.11% of its industry peers.
IBM's Profit Margin has declined in the last couple of years.
IBM has a Operating Margin of 15.32%. This is amongst the best in the industry. IBM outperforms 81.93% of its industry peers.
IBM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 57.57%, IBM is in the better half of the industry, outperforming 78.31% of the companies in the same industry.
IBM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.32%
PM (TTM) 9.11%
GM 57.57%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
IBM Yearly Profit, Operating, Gross MarginsIBM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IBM is destroying value.
Compared to 1 year ago, IBM has more shares outstanding
Compared to 5 years ago, IBM has more shares outstanding
Compared to 1 year ago, IBM has an improved debt to assets ratio.
IBM Yearly Shares OutstandingIBM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IBM Yearly Total Debt VS Total AssetsIBM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 3.16 indicates that IBM is not in any danger for bankruptcy at the moment.
The Altman-Z score of IBM (3.16) is comparable to the rest of the industry.
IBM has a debt to FCF ratio of 5.46. This is a neutral value as IBM would need 5.46 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.46, IBM perfoms like the industry average, outperforming 55.42% of the companies in the same industry.
A Debt/Equity ratio of 2.01 is on the high side and indicates that IBM has dependencies on debt financing.
The Debt to Equity ratio of IBM (2.01) is worse than 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.01
Debt/FCF 5.46
Altman-Z 3.16
ROIC/WACC0.81
WACC9.28%
IBM Yearly LT Debt VS Equity VS FCFIBM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

IBM has a Current Ratio of 0.91. This is a bad value and indicates that IBM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.91, IBM is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
A Quick Ratio of 0.87 indicates that IBM may have some problems paying its short term obligations.
With a Quick ratio value of 0.87, IBM is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.87
IBM Yearly Current Assets VS Current LiabilitesIBM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

IBM shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.32%.
Measured over the past years, IBM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.21% on average per year.
The Revenue has been growing slightly by 2.69% in the past year.
IBM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.69% yearly.
EPS 1Y (TTM)4.32%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.23%
Revenue 1Y (TTM)2.69%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%7.65%

3.2 Future

The Earnings Per Share is expected to grow by 6.21% on average over the next years.
IBM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y8.66%
EPS Next 2Y7.71%
EPS Next 3Y6.93%
EPS Next 5Y6.21%
Revenue Next Year6.36%
Revenue Next 2Y5.36%
Revenue Next 3Y5.02%
Revenue Next 5Y4.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IBM Yearly Revenue VS EstimatesIBM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
IBM Yearly EPS VS EstimatesIBM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

IBM is valuated rather expensively with a Price/Earnings ratio of 22.80.
60.24% of the companies in the same industry are more expensive than IBM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of IBM to the average of the S&P500 Index (27.24), we can say IBM is valued inline with the index average.
A Price/Forward Earnings ratio of 20.20 indicates a rather expensive valuation of IBM.
The rest of the industry has a similar Price/Forward Earnings ratio as IBM.
When comparing the Price/Forward Earnings ratio of IBM to the average of the S&P500 Index (22.81), we can say IBM is valued inline with the index average.
Industry RankSector Rank
PE 22.8
Fwd PE 20.2
IBM Price Earnings VS Forward Price EarningsIBM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

IBM's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBM indicates a somewhat cheap valuation: IBM is cheaper than 71.08% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.18
EV/EBITDA 18.5
IBM Per share dataIBM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IBM does not grow enough to justify the current Price/Earnings ratio.
IBM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.63
PEG (5Y)N/A
EPS Next 2Y7.71%
EPS Next 3Y6.93%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.81%, IBM has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.44, IBM pays a better dividend. On top of this IBM pays more dividend than 95.18% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, IBM pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

The dividend of IBM has a limited annual growth rate of 0.83%.
IBM has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of IBM decreased in the last 3 years.
Dividend Growth(5Y)0.83%
Div Incr Years2
Div Non Decr Years2
IBM Yearly Dividends per shareIBM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

106.31% of the earnings are spent on dividend by IBM. This is not a sustainable payout ratio.
The dividend of IBM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP106.31%
EPS Next 2Y7.71%
EPS Next 3Y6.93%
IBM Yearly Income VS Free CF VS DividendIBM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
IBM Dividend Payout.IBM Dividend Payout, showing the Payout Ratio.IBM Dividend Payout.PayoutRetained Earnings

INTL BUSINESS MACHINES CORP

NYSE:IBM (8/22/2025, 8:14:57 PM)

After market: 242.38 +0.29 (+0.12%)

242.09

+2.69 (+1.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners65.2%
Inst Owner Change-1.2%
Ins Owners0.09%
Ins Owner Change-0.66%
Market Cap225.51B
Analysts71.11
Price Target280.67 (15.94%)
Short Float %1.68%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend6.68
Dividend Growth(5Y)0.83%
DP106.31%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-08 2025-08-08 (1.68)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.93%
Min EPS beat(2)4.89%
Max EPS beat(2)12.97%
EPS beat(4)4
Avg EPS beat(4)5.93%
Min EPS beat(4)2.27%
Max EPS beat(4)12.97%
EPS beat(8)8
Avg EPS beat(8)5.15%
EPS beat(12)11
Avg EPS beat(12)4.65%
EPS beat(16)14
Avg EPS beat(16)3.57%
Revenue beat(2)2
Avg Revenue beat(2)0.68%
Min Revenue beat(2)0.01%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.31%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.52%
Revenue beat(12)4
Avg Revenue beat(12)-0.27%
Revenue beat(16)7
Avg Revenue beat(16)-1.44%
PT rev (1m)3.83%
PT rev (3m)10.08%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)-1.32%
EPS NY rev (1m)1.96%
EPS NY rev (3m)1.68%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)2.89%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 22.8
Fwd PE 20.2
P/S 3.52
P/FCF 19.18
P/OCF 16.98
P/B 8.2
P/tB N/A
EV/EBITDA 18.5
EPS(TTM)10.62
EY4.39%
EPS(NY)11.99
Fwd EY4.95%
FCF(TTM)12.62
FCFY5.21%
OCF(TTM)14.26
OCFY5.89%
SpS68.75
BVpS29.53
TBVpS-56.09
PEG (NY)2.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.93%
ROE 21.2%
ROCE 8.85%
ROIC 7.55%
ROICexc 8.78%
ROICexgc 53.5%
OM 15.32%
PM (TTM) 9.11%
GM 57.57%
FCFM 18.36%
ROA(3y)3.74%
ROA(5y)3.83%
ROE(3y)20.94%
ROE(5y)24.07%
ROIC(3y)7.26%
ROIC(5y)6.26%
ROICexc(3y)8.29%
ROICexc(5y)7.07%
ROICexgc(3y)40.75%
ROICexgc(5y)31.79%
ROCE(3y)8.5%
ROCE(5y)7.33%
ROICexcg growth 3Y26.58%
ROICexcg growth 5Y17.04%
ROICexc growth 3Y17.55%
ROICexc growth 5Y7.25%
OM growth 3Y13.36%
OM growth 5Y1.77%
PM growth 3Y-1.4%
PM growth 5Y-10.1%
GM growth 3Y1.05%
GM growth 5Y0.73%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 2.01
Debt/FCF 5.46
Debt/EBITDA 3.77
Cap/Depr 31.62%
Cap/Sales 2.38%
Interest Coverage 250
Cash Conversion 90.78%
Profit Quality 201.58%
Current Ratio 0.91
Quick Ratio 0.87
Altman-Z 3.16
F-Score5
WACC9.28%
ROIC/WACC0.81
Cap/Depr(3y)35.46%
Cap/Depr(5y)39.55%
Cap/Sales(3y)2.66%
Cap/Sales(5y)3.73%
Profit Quality(3y)294.17%
Profit Quality(5y)264.98%
High Growth Momentum
Growth
EPS 1Y (TTM)4.32%
EPS 3Y1.19%
EPS 5Y-4.21%
EPS Q2Q%15.23%
EPS Next Y8.66%
EPS Next 2Y7.71%
EPS Next 3Y6.93%
EPS Next 5Y6.21%
Revenue 1Y (TTM)2.69%
Revenue growth 3Y3.05%
Revenue growth 5Y1.69%
Sales Q2Q%7.65%
Revenue Next Year6.36%
Revenue Next 2Y5.36%
Revenue Next 3Y5.02%
Revenue Next 5Y4.94%
EBIT growth 1Y8.54%
EBIT growth 3Y16.81%
EBIT growth 5Y3.49%
EBIT Next Year72.78%
EBIT Next 3Y26.23%
EBIT Next 5Y19.31%
FCF growth 1Y14.17%
FCF growth 3Y7.1%
FCF growth 5Y0.76%
OCF growth 1Y8.18%
OCF growth 3Y1.67%
OCF growth 5Y-1.86%